GlassScriptPhysician profile
Zabeer Bhatti
NPI 1619354701
$54,906.23
in general payments reported to CMS, 2019-2025
10 companies · $3,054 in 2025
The $3,054 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $78.18 · 2021: $20K · 2022: $25K · 2023: $4,653 · 2024: $1,071 · 2025: $3,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,423 · Travel and Lodging: $1,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,422.73 |
| Travel and Lodging | $1,355.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $42,878.77 | 2021-2024 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan, Cardioblate Cryoflex |
| Abbott Laboratories | $8,364.13 | 2019-2025 | Aveir, Advisor, Ensite |
| Biosense Webster, INC. | $1,522.52 | 2021-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Biotronik INC. | $1,407.38 | 2023-2025 | Biomonitor, Amvia Edge, Pamira |
| Boston Scientific Corporation | $492.55 | 2020-2025 | Farapulse, Essentio Sr, Watchman Flx |
| Astellas Pharma US INC | $111.32 | 2019 | |
| Sanofi-Aventis U.S. LLC | $38.60 | 2022 | |
| Impulse Dynamics (USA) INC. | $37.50 | 2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $34.48 | 2020 | |
| Philips North America LLC | $18.98 | 2024 | (5044) Mcot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zabeer Bhatti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.